Adalimumab reduces spinal symptoms in active ankylosing spondylitis: clinical and magnetic resonance imaging results of a fifty-two-week openlabel trial

被引：124
|
作者：
Haibel, H [1 ]
Rudwaleit, M
Brandt, HC
Grozdanovic, Z
Listing, J
Kupper, H
Braun, J
Sieper, J
机构：
[1] Klinikum Benjamin Franklin, D-12200 Berlin, Germany
[2] German Rheumatism Res Ctr, Berlin, Germany
[3] Abbott GmbH & Co, Ludwigshafen, Germany
[4] Ctr Rheumatol Ruhrgebiet, Herne, Germany
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 02期
关键词：
D O I：
10.1002/art.21563
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：678 / 681
页数：4
相关论文
共 50 条
  • [1] Evaluation of the efficacy of etoricoxib in ankylosing spondylitis - Results of a fifty-two-week, randomized, controlled study
    van der Heijde, D
    Baraf, HSB
    Ramos-Remus, C
    Calin, A
    Weaver, AL
    Schiff, M
    James, M
    Markind, JE
    Reicin, AS
    Melian, A
    Dougados, M
    ARTHRITIS AND RHEUMATISM, 2005, 52 (04): : 1205 - 1215
  • [2] Adalimumab reduces spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis (AS) - 52 week magnetic resonance imaging (MRI) results from the Canadian AS study
    Lambert, R. G. W.
    Salonen, D.
    Rahman, P.
    Inman, R.
    Wong, R.
    Patra, K.
    Thomson, G. T. D.
    Beaulieu, A.
    Choquette, D.
    Maksymowych, W. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 65 - 65
  • [3] Adalimumab reduces spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis (AS): 52-week magnetic resonance imaging (MRI) results from the Canadian AS study.
    Lambert, R. G. W.
    Salonen, D. C.
    Rahman, P.
    Inman, R. D.
    Wong, R.
    Patra, K.
    Thomson, G. T. D.
    Beaulieu, A. D.
    Choquette, D.
    Maksymowych, W. P.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S799 - S800
  • [4] Adalimumab effectively reduces the signs and symptoms of active ankylosing spondylitis in patients with total spinal ankylosis
    van der Heijde, D.
    Pangan, A. L.
    Schiff, M. H.
    Braun, J.
    Borofsky, M.
    Torre, J.
    Davis, J. C.
    Wong, R. L.
    Kupper, H.
    Collantes, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (09) : 1218 - 1221
  • [5] Adalimumab therapy significantly reduces signs and symptoms in patients with Ankylosing Spondylitis (AS): Results of the atlas trial
    van der Heijde, D.
    Kivitz, A.
    Schiff, M.
    Sieper, J.
    Dijkmans, B.
    Braun, J.
    Dougados, M.
    Reveille, J.
    Wong, R.
    Kupper, H.
    Davis, J.
    RHEUMATOLOGY, 2006, 45 : I6 - I6
  • [6] Adalimumab in the treatment of active ankylosing spondylitis: Results of an open-label, 52-week trial
    Haibel, H
    Brandt, H
    Baraliakos, X
    Rudwaleit, M
    Listing, J
    Braun, J
    Kupper, H
    Sieper, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 316 - 316
  • [7] Adalimumab achieve significant improvement in active ankylosing spondylitis patients assessed by magnetic resonance imaging
    Carrasco, J. A.
    Martos, J.
    Guijo, V. Perez
    Font, P.
    Castro, M.
    Munoz, E.
    Munoz, M.
    Miranda, M.
    Ruiz, A.
    Cano, A.
    Collantes, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 391 - 391
  • [8] EFFICACY OF ANAKINRA IN ACTIVE ANKYLOSING SPONDYLITIS: A CLINICAL AND MAGNETIC RESONANCE IMAGING STUDY
    Tan, A. L.
    Marzo-Ortega, H.
    O'Connor, P.
    Fraser, A.
    Emery, P.
    McGonagle, D.
    RHEUMATOLOGY, 2004, 43 : 10 - 11
  • [9] Preliminary results of an open-label, 12-week trial of adalimumab in the treatment of active ankylosing spondylitis
    Haibel, H
    Brandt, HC
    Rudwaleit, M
    Listing, J
    Braun, J
    Kupper, H
    Sieper, J
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 399 - 399
  • [10] Efficacy of anakinra in active ankylosing spondylitis: a clinical and magnetic resonance imaging study
    Tan, AL
    Marzo-Ortega, H
    O'Connor, P
    Fraser, A
    Emery, P
    McGonagle, D
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (09) : 1041 - 1045
12345